A Phase II Clinical Study of HRS-1893 in Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

Conditions

Non-obstructive Hypertrophic Cardiomyopathy

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fuwai Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Lianming Kang) · lianmingkang@126.com · 010-88396870
Contact: Principal Investigator (Lianming Kang)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients With Symptomatic Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE2

La Jolla, United States · Los Angeles, United States

A Study to Evaluate the Efficacy and Safety of Sotagliflozin in Symptomatic Obstructive and Non-obstructive Hypertrophic Cardiomyopathy

Obstructive Cardiomyopathy, Hypertrophic · Non-obstructive Hypertrophic Cardiomyopathy

IsraelRecruitingPHASE3

Phoenix, United States · Scottsdale, United States

Treatment Effects of Bisoprolol and Verapamil in Symptomatic Patients With Non-obstructive Hypertrophic Cardiomyopathy

Non-obstructive Hypertrophic Cardiomyopathy

Abroad (travel likely)RecruitingPHASE4

Aarhus N, Denmark · Odense, Denmark

Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy

Hypertrophic Cardiomyopathy

Abroad (travel likely)Recruiting

San Francisco, United States